 | • レポートコード：MRC2305B245 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、223ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に167.3億ドルであった世界の血管ステント市場規模が、2022年には188.9億ドルに達し、2027年までに年平均13.12％成長して350.7億ドルになると予測しています。当調査資料では、血管ステントの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（ベアメタルステント、バイオエンジニアリングステント、生体吸収性血管足場、薬剤溶出ステント、デュアルセラピーステント）、材料別分析（金属、ポリマー）、送達方法別分析（バルーン拡張型ステント、自己拡張型ステント）、製品別分析（冠動脈ステント、EVARステントグラフト、末梢ステント）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、Abbott Laboratories、B. Braun Melsungen AG、Becton, Dickinson and Company、Biosensors International Group, Ltd.、Biotronik SE & Co. KG、Boston Scientific Corporation、Cook Medical, Inc、CryoLife, Inc.、Elixir Medical Corporation、Endologix, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の血管ステント市場規模：種類別 - ベアメタルステントの市場規模 - バイオエンジニアリングステントの市場規模 - 生体吸収性血管足場の市場規模 - 薬剤溶出ステントの市場規模 - デュアルセラピーステントの市場規模 ・世界の血管ステント市場規模：材料別 - 金属の市場規模 - ポリマーの市場規模 ・世界の血管ステント市場規模：送達方法別 - バルーン拡張型ステントの市場規模 - 自己拡張型ステントの市場規模 ・世界の血管ステント市場規模：製品別 - 冠動脈ステントの市場規模 - EVARステントグラフトの市場規模 - 末梢ステントの市場規模 ・世界の血管ステント市場規模：地域別 - 南北アメリカの血管ステント市場規模 アメリカの血管ステント市場規模 カナダの血管ステント市場規模 ブラジルの血管ステント市場規模 ... - アジア太平洋の血管ステント市場規模 日本の血管ステント市場規模 中国の血管ステント市場規模 インドの血管ステント市場規模 韓国の血管ステント市場規模 台湾の血管ステント市場規模 ... - ヨーロッパ/中東/アフリカの血管ステント市場規模 イギリスの血管ステント市場規模 ドイツの血管ステント市場規模 フランスの血管ステント市場規模 ロシアの血管ステント市場規模 ... - その他地域の血管ステント市場規模 ・競争状況 ・企業情報 |
The Global Vascular Stent Market size was estimated at USD 16.73 billion in 2021 and expected to reach USD 18.89 billion in 2022, and is projected to grow at a CAGR 13.12% to reach USD 35.07 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Vascular Stent to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Bare Metal Stent, Bio-engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, and Dual Therapy Stent.
Based on Material, the market was studied across Metallic Stent and Polymer.
Based on Mode of Delivery, the market was studied across Balloon-expandable Stent and Self-expanding Stent.
Based on Product, the market was studied across Coronary Stent, Evar Stent Graft, and Peripheral Stent. The Evar Stent Graft is further studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. The Peripheral Stent is further studied across Carotid Stent, Femoral Stent, Iliac Stent, and Renal Artery Stent.
Based on End User, the market was studied across Ambulatory Surgical Center, Cardiac Center, and Hospital.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vascular Stent market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vascular Stent Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vascular Stent Market, including Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc, CryoLife, Inc., Elixir Medical Corporation, Endologix, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Stentys S.A., Stryker Corporation, Terumo Corporation, Translumina Gmbh By Everstone Capital, and W. L. Gore & Associates, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Vascular Stent Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Stent Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Stent Market?
4. What is the competitive strategic window for opportunities in the Global Vascular Stent Market?
5. What are the technology trends and regulatory frameworks in the Global Vascular Stent Market?
6. What is the market share of the leading vendors in the Global Vascular Stent Market?
7. What modes and strategic moves are considered suitable for entering the Global Vascular Stent Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of vascular diseases and growth in geriatric population
5.1.1.2. Developments in stenting technologies
5.1.1.3. Rising demand for minimally invasive medical procedures
5.1.2. Restraints
5.1.2.1. Availability of alternative medical treatments and product recalls
5.1.3. Opportunities
5.1.3.1. Focus on bioresorbable stents developments
5.1.3.2. Collaborative strategic initiatives for business expansion
5.1.4. Challenges
5.1.4.1. Chances of intravascular injuries
5.2. Cumulative Impact of COVID-19
6. Vascular Stent Market, by Type
6.1. Introduction
6.2. Bare Metal Stent
6.3. Bio-engineered Stent
6.4. Bioresorbable Vascular Scaffold
6.5. Drug Eluting Stent
6.6. Dual Therapy Stent
7. Vascular Stent Market, by Material
7.1. Introduction
7.2. Metallic Stent
7.3. Polymer
8. Vascular Stent Market, by Mode of Delivery
8.1. Introduction
8.2. Balloon-expandable Stent
8.3. Self-expanding Stent
9. Vascular Stent Market, by Product
9.1. Introduction
9.2. Coronary Stent
9.3. Evar Stent Graft
9.4.1. Abdominal Aortic Aneurysm
9.4.2. Thoracic Aortic Aneurysm
9.4. Peripheral Stent
9.5.1. Carotid Stent
9.5.2. Femoral Stent
9.5.3. Iliac Stent
9.5.4. Renal Artery Stent
10. Vascular Stent Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Cardiac Center
10.4. Hospital
11. Americas Vascular Stent Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Vascular Stent Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Vascular Stent Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. B. Braun Melsungen AG
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Becton, Dickinson and Company
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Biosensors International Group, Ltd.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Biotronik SE & Co. KG
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Boston Scientific Corporation
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cook Medical, Inc
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. CryoLife, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Elixir Medical Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Endologix, Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Medtronic PLC
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Meril Life Sciences Pvt. Ltd
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Microport Scientific Corporation
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Otsuka Medical Devices Co., Ltd.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Purple Medical Solution Pvt. Ltd
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Sahajanand Medical Technologies Pvt. Ltd
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Stentys S.A.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Stryker Corporation
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Terumo Corporation
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Translumina Gmbh By Everstone Capital
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. W. L. Gore & Associates, Inc.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing